(PDF) Comparison of Half and Full Doses of an

Comparison of Half and Full Doses of an MF59-adjuvanted Cell Culture-Derived a/H1N1v Vaccine in Japanese Children

Advances in Therapy - United States

doi 10.1007/s12325-010-0043-4

Full Text

Abstract

Available in full text

Categories

Date

June 25, 2010

Authors

Kenji Matsushita

Taketsugu Minami

Publisher

Springer Science and Business Media LLC

Related search

Influenza Vaccination in Children Primed With MF59®-adjuvanted or Non-Adjuvanted Seasonal Influenza Vaccine

Human Vaccines and Immunotherapeutics

English

Cumulative Clinical Experience With MF59-Adjuvanted Trivalent Seasonal Influenza Vaccine in Young Children

International Journal of Infectious Diseases

Infectious Diseases

English

AS03- And MF59-Adjuvanted Influenza Vaccines in Children

Frontiers in Immunology

English

Safety and Immunogenicity of HCV E1E2 Vaccine Adjuvanted With MF59 Administered to Healthy Adults

Molecular Medicine

Infectious Diseases

Occupational Health

English

Influenza a/H1n1 MF59 Adjuvanted Vaccine in Pregnant Women and Adverse Perinatal Outcomes: Multicentre Study

British Medical Journal

English

Comparison of the Adverse Events Associated With MF59-Adjuvanted and Non-Adjuvanted H1N1 Vaccines in Healthy Young Male Korean Soldiers

Japanese Journal of Infectious Diseases

Infectious Diseases

English

MF59-Adjuvanted Seasonal Trivalent Influenza Vaccine: Pooled Analysis of Safety in Older Adults ≥65 Years of Age

International Journal of Infectious Diseases

Infectious Diseases

English

An Adjuvanted Whole Cell Vaccine as Post-Remission Immunotherapy for Acute Leukemia

English

Preparation of Inactivated Tissue Culture Rabies Vaccine Adjuvanted With Natural Immune Stimulants

Journal of Veterinary Medical Research

English